GSK_Annual_Report_2021

Notes to the Standalone Financial Statements for the year ended March 31, 2021 (contd.) Annual Report 2020-21 141 Wellcome Consumer Healthcare Limited, U.K.* * no transactions during the year (ii) Subsidiary of the Company : Biddle Sawyer Limited, a wholly owned subsidiary of the Company (iii) Other related parties in the GlaxoSmithKline (GSK) Group where common control exists and with whom the Company had transactions during the year: GlaxoSmithKline Asia Private Limited, India GlaxoSmithKline Brasil Ltda, Brazil* GlaxoSmithKline Consumer Healthcare Limited, India* GlaxoSmithKline Biologicals S.A., Belgium GlaxoSmithKline Pharmaceuticals S.A., Belgium GlaxoSmithKline Services Unlimited, U.K. Glaxo Operations UK Limited, U.K Laboratoire GlaxoSmithKline S.A.S., France* GlaxoSmithKline Pharmaceutical Sdn Bhd, Malaysia GlaxoSmithKline Export Limited, U.K. SmithKline Beecham Pharmaceuticals , U.S.A GlaxoSmithKline Latin America S.A* GlaxoSmithKline Pakistan Limited, Pakistan* GlaxoSmithKline Research & Development Ltd, U.K GlaxoSmithKline Corporate Centre, U.S.A* GlaxoSmithkline Philippines Inc., Philippines* GlaxoSmithKline Australia Pty Limited, Australia* GlaxoSmithKline Canada Inc, Canada* GlaxoSmithKline Trading Services Limited, Ireland GlaxoSmithKline Limited, Hong Kong* GlaxoSmithKline South Africa (Pty) Ltd, South Africa GlaxoSmithKline LLC, U.S.A* GlaxoSmithKline Limited, Kenya* GlaxoSmithKline Pharmaceutical Nigeria Limited, Nigeria* Stiefel India Private Limited, India GSK India Global Services Private Limited Glaxo Wellcome Ceylon Ltd., Sri Lanka* US Pharmaceuticals, U.S.A.* GlaxoSmithKline Pharmaceutical Ltd., Sri Lanka ViiV Healthcare Limited, U.K.* US GMS Financial Services, U.S.A.*